H. Graeff

9.6k total citations
210 papers, 7.5k citations indexed

About

H. Graeff is a scholar working on Cancer Research, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. Graeff has authored 210 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Cancer Research, 51 papers in Hematology and 46 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. Graeff's work include Protease and Inhibitor Mechanisms (64 papers), Blood Coagulation and Thrombosis Mechanisms (45 papers) and Blood properties and coagulation (31 papers). H. Graeff is often cited by papers focused on Protease and Inhibitor Mechanisms (64 papers), Blood Coagulation and Thrombosis Mechanisms (45 papers) and Blood properties and coagulation (31 papers). H. Graeff collaborates with scholars based in Germany, United States and Japan. H. Graeff's co-authors include Manfred Schmitt, F. Jänicke, Nadia Harbeck, Olaf G. Wilhelm, Kurt Ulm, W. Kühn, R. Hafter, L. Pache, Heinz Höfler and Markus Schwaiger and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

H. Graeff

201 papers receiving 7.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Graeff Germany 44 4.0k 2.2k 2.0k 1.6k 1.3k 210 7.5k
Giampietro Gasparini Italy 43 3.4k 0.9× 4.1k 1.8× 5.0k 2.5× 395 0.2× 978 0.8× 170 9.8k
Christoph Thomssen Germany 53 4.5k 1.1× 4.9k 2.2× 2.2k 1.1× 526 0.3× 810 0.6× 281 8.4k
Michael S. O’Reilly United States 36 4.6k 1.2× 3.4k 1.5× 7.5k 3.8× 568 0.4× 1.2k 0.9× 79 12.0k
Ronit Simantov United States 36 2.6k 0.7× 3.3k 1.5× 5.5k 2.8× 857 0.5× 647 0.5× 88 11.2k
Dan Eaton United States 43 1.8k 0.4× 2.4k 1.1× 2.5k 1.3× 5.3k 3.3× 670 0.5× 76 11.7k
P Pouillart France 55 3.2k 0.8× 5.1k 2.3× 1.5k 0.8× 342 0.2× 620 0.5× 262 9.1k
Hans Tesch Germany 49 2.7k 0.7× 5.3k 2.4× 1.6k 0.8× 706 0.4× 1.4k 1.1× 346 9.5k
Thomas M. Grogan United States 52 831 0.2× 5.0k 2.2× 3.1k 1.6× 1.2k 0.8× 846 0.7× 160 9.2k
Martin F. Fey Switzerland 49 1.6k 0.4× 3.0k 1.3× 3.1k 1.6× 2.1k 1.3× 229 0.2× 189 8.0k
Giannoula Klement United States 29 1.2k 0.3× 1.7k 0.8× 2.3k 1.2× 847 0.5× 240 0.2× 67 4.9k

Countries citing papers authored by H. Graeff

Since Specialization
Citations

This map shows the geographic impact of H. Graeff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Graeff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Graeff more than expected).

Fields of papers citing papers by H. Graeff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Graeff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Graeff. The network helps show where H. Graeff may publish in the future.

Co-authorship network of co-authors of H. Graeff

This figure shows the co-authorship network connecting the top 25 collaborators of H. Graeff. A scholar is included among the top collaborators of H. Graeff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Graeff. H. Graeff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kühn, W., Jörg Nährig, Martin Werner, et al.. (2000). Detection of micrometastases in sentinel lymph nodes of the breast applying monoclonal antibodies AE1/AE3 to pancytokeratins.. Oncology Reports. 7(4). 745–9. 8 indexed citations
2.
Harbeck, Nadia, Jeffrey S. Ross, P. Dettmar, et al.. (1999). HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.. International Journal of Oncology. 14(4). 663–71. 35 indexed citations
3.
Harbeck, Nadia, P. Dettmar, Christoph Thomssen, et al.. (1998). Prognostic impact of tumor biological factors on survival in node-negative breast cancer.. PubMed. 18(3C). 2187–97. 44 indexed citations
4.
Kühn, W., G. Florack, J. D. Roder, et al.. (1998). The influence of upper abdominal surgery on perioperative morbidity and mortality in patients with advanced ovarian cancer FIGO III and FIGO IV. International Journal of Gynecological Cancer. 8(1). 56–63. 45 indexed citations
5.
Dose, J., Norbert Avril, H. Graeff, & F. Jänicke. (1997). Positron Emission Tomography for Diagnosis of Breast Tumors. Oncology Research and Treatment. 20(3). 190–195. 2 indexed citations
6.
Schmitt, Manfred, Barbara Schmalfeldt, Paul Trommler, et al.. (1997). Mutational analysis of the genes encoding urokinase‐type plasminogen activator (uPA) and its inhibitor PAI‐1 in advanced ovarian cancer. Electrophoresis. 18(5). 686–689. 16 indexed citations
7.
Schelling, M., Michael Braun, Robert Busch, et al.. (1997). Optimized differential diagnosis of breast lesions by combined B‐mode and color Doppler sonography. Ultrasound in Obstetrics and Gynecology. 10(1). 48–53. 16 indexed citations
8.
Schmalfeldt, Barbara, W. Kühn, Ute Reuning, et al.. (1995). Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2.. PubMed. 55(18). 3958–63. 85 indexed citations
9.
Fischbach, Frank, R. Deckardt, & H. Graeff. (1994). Ciprofloxacin/Metronidazol vs. Cefoxitin/Doxycyclin: Vergleich zweier Therapieschemata zur Behandlung der akuten pelvinen Infektion. Geburtshilfe und Frauenheilkunde. 54(6). 337–340. 6 indexed citations
10.
Wilhelm, Sabine, Olaf G. Wilhelm, Martina Schmitt, & H. Graeff. (1994). Inactivation of Receptor-Bound Pro-Urokinase-Type Plasminogen Activator (pro-uPA) by Thrombin and Thrombin/Thrombomodulin Complex. Biological Chemistry Hoppe-Seyler. 375(9). 603–608. 12 indexed citations
11.
Jänicke, F., et al.. (1994). [Secondary debulking operation in ovarian cancer].. PubMed. 65(1). 10–7. 1 indexed citations
12.
Kolben, M., et al.. (1993). Die Bedeutung der PMN-Granulozyten-Elastase-Konzentrationsbestimmung im Plasma von Schwangeren mit vorzeitigem Blasensprung. Geburtshilfe und Frauenheilkunde. 53(2). 81–85. 2 indexed citations
13.
Graeff, H., F. Jänicke, & Markus Schmitt. (1991). Klinische und prognostische Bedeutung tumorassoziierter Proteasen in der gynäkologischen Onkologie*. Geburtshilfe und Frauenheilkunde. 51(2). 90–99. 5 indexed citations
14.
Harbeck, Nadia, Nobuhiko Moniwa, Evan L. Busch, et al.. (1991). Durchflußzytometrische DNA-Analyse von reinen Zellkernen aus formalin-fixierten Paraffinschnitten beim primären Mammakarzinom: Korrelation mit anderen Prognosefaktoren. Gyn�kologisch-geburtshilfliche Rundschau. 31(Suppl. 2). 299–302.
15.
Schmitt, Manfred, et al.. (1991). Clinical Relevance of the Urokinase-Type and Tissue-Type Plasminogen Activators and of Their Type 1 Inhibitor in Breast Cancer. Seminars in Thrombosis and Hemostasis. 17(3). 303–312. 202 indexed citations
16.
Rath, Werner, et al.. (1990). The importance of early laboratory screening methods for maternal and fetal outcome in cases of HELLP syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 36(1-2). 43–51. 23 indexed citations
17.
Fischbach, Frank, et al.. (1988). Genitale Infektionen und Schwangerschaftsverlauf: Eine prospektive Studie. Geburtshilfe und Frauenheilkunde. 48(7). 469–478. 8 indexed citations
18.
Hiller, Erhard, Hanno Riess, R. Hafter, & H. Graeff. (1980). Evaluation of hypercoagulability after remission induction chemotherapy of acute leukemia. Annals of Hematology. 41(5). 359–366. 1 indexed citations
19.
Ishikawa, Akio, R. Hafter, U Seemüller, J. M. Gokel, & H. Graeff. (1980). The effect of hirudin on endotoxin induced disseminated intravascular coagulation (DIC). Thrombosis Research. 19(3). 351–358. 19 indexed citations
20.
Graeff, H., et al.. (1978). [Pathomechanisms, signs, symptoms and management of amniotic fluid embolism (author's transl)].. PubMed. 38(11). 887–94. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giampietro Gasparini Breakdown of academic impact, for papers by Christoph Thomssen Breakdown of academic impact, for papers by Michael S. O’Reilly Breakdown of academic impact, for papers by Ronit Simantov Breakdown of academic impact, for papers by Dan Eaton Breakdown of academic impact, for papers by P Pouillart Breakdown of academic impact, for papers by Hans Tesch Breakdown of academic impact, for papers by Thomas M. Grogan Breakdown of academic impact, for papers by Martin F. Fey Breakdown of academic impact, for papers by Giannoula Klement
Rankless by CCL
2026